Global Minimally Invasive Surgery Devices Market Size By Type (Handheld Instruments, Inflation Systems), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Minimally Invasive Surgery (MIS) Devices Market was valued at USD 27.9 billion in 2023 and is projected to reach USD 49.6 billion by 2031, growing at a CAGR of 7.5% from 2023 to 2031. This growth is fueled by increasing demand for faster recovery times, reduced post-operative pain, and shorter hospital stays. The continuous evolution of surgical technologies, rising geriatric population, and growing prevalence of chronic diseases such as cancer and cardiovascular disorders are further accelerating the adoption of minimally invasive procedures globally.

Drivers:

1. Increasing Preference for Minimally Invasive Procedures

Patients and surgeons alike prefer MIS due to benefits like reduced blood loss, less pain, shorter recovery times, and minimized scarring. This shift is significantly driving market demand.

2. Rising Geriatric Population and Chronic Disease Prevalence

As the global population ages, the number of surgical interventions for age-related diseases—especially orthopedic and cardiovascular conditions—is rising, fueling the market.

3. Technological Advancements in Surgical Devices

Innovations such as robot-assisted surgical systems, 3D imaging, and advanced endoscopy are making MIS safer, more precise, and applicable to a wider range of conditions.

Restraints:

1. High Equipment Costs and Skilled Personnel Requirements

Advanced MIS systems often involve high capital investment and require trained surgeons and operating staff. This presents a significant barrier, especially in developing regions.

2. Regulatory and Reimbursement Challenges

Stringent regulatory frameworks and complex reimbursement scenarios can delay product approvals and market entry, affecting overall growth momentum.

Opportunity:

1. Surge in Robotic-Assisted Surgeries

The rise in robotic-assisted MIS, particularly in urology and gynecology, opens up major growth avenues. Robotic systems offer improved dexterity and precision in complex surgeries.

2. Expansion in Emerging Economies

Rapidly growing healthcare infrastructure in countries such as India, Brazil, and China, coupled with government initiatives to improve surgical care, are presenting lucrative opportunities for MIS device manufacturers.

Market by System Type Insights:

By system type, Laparoscopic Devices held the largest market share in 2023. Their extensive use in gastrointestinal, gynecological, and bariatric procedures, combined with continuous enhancements in visualization and instrument control, sustain their dominance. The robotic-assisted surgical systems segment is projected to witness the fastest growth due to rising adoption in advanced surgical procedures and improved clinical outcomes.

Market by End-use Insights:

Hospitals accounted for the largest end-use segment in 2023, holding over 50% of the market share. The wide availability of advanced surgical equipment, higher procedure volumes, and access to skilled professionals contribute to this segment's dominance. Ambulatory Surgical Centers (ASCs) are expected to grow significantly during the forecast period due to cost-effectiveness and shorter turnaround times.

Market by Regional Insights:

North America led the market in 2023, driven by favorable reimbursement policies, advanced healthcare infrastructure, and strong presence of key players. However, Asia-Pacific is forecasted to grow at the highest CAGR, bolstered by increased healthcare investments, rising patient awareness, and growing adoption of advanced surgical techniques in developing countries.

Competitive Scenario:

Key players in the Global Minimally Invasive Surgery Devices Market include:

Medtronic plc

Johnson & Johnson (Ethicon Inc.)

Stryker Corporation

Olympus Corporation

Intuitive Surgical, Inc.

Smith & Nephew plc

B. Braun Melsungen AG

Zimmer Biomet Holdings, Inc.

Karl Storz SE & Co. KG

ConMed Corporation

These companies are focusing on strategic partnerships, product innovations, and geographical expansion to enhance their competitive positioning. Notable developments include:

2023: Intuitive Surgical expanded its da Vinci robotic platform portfolio with new instruments tailored for thoracic and colorectal procedures.

2024: Medtronic introduced an AI-integrated laparoscopic visualization system to enhance surgical accuracy and reduce complications.

2025: Stryker acquired a minimally invasive spine device firm to strengthen its position in the spinal surgery segment.

Scope of Work – Global Minimally Invasive Surgery Devices Market

Key Market Developments:

April 2023: Olympus Corporation introduced a next-gen 4K laparoscopic imaging system featuring fluorescence-guided surgery capabilities.

August 2024: Johnson & Johnson’s Ethicon unit launched a reusable energy device for MIS to reduce procedural costs and enhance sustainability.

March 2025: Smith & Nephew entered a strategic alliance with a robotic software developer to enhance performance tracking and analytics in MIS.

FAQs:

1. What is the current market size of the Global Minimally Invasive Surgery Devices Market?

The market was valued at USD 27.9 billion in 2023.

2. What is the major growth driver of the Global Minimally Invasive Surgery Devices Market?

The primary growth driver is the increasing demand for procedures with reduced recovery time, pain, and hospital stay.

3. Which is the largest region during the forecast period in the Global Minimally Invasive Surgery Devices Market?

North America held the largest market share in 2023, but Asia-Pacific is expected to witness the highest growth through 2031.

4. Which segment accounted for the largest market share in the Global Minimally Invasive Surgery Devices Market?

Laparoscopic Devices were the leading segment by system type in 2023.

5. Who are the key market players in the Global Minimally Invasive Surgery Devices Market?

Major players include Medtronic, Johnson & Johnson, Intuitive Surgical, Stryker, Olympus, and Smith & Nephew.